Pagari PharmaTech

Executive Summary

Pagari PharmaTech is a US-based, quality-driven CDMO founded in 2020, specializing in solid and liquid oral dosage forms. It offers end-to-end services from R&D and analytical development to technology transfer and commercial manufacturing. With a focus on client-first approach and regulatory compliance, the company aims to serve the growing demand for reliable oral drug manufacturing in North America. Despite being in pre-clinical stage as a service provider, Pagari has established a presence in San Diego, a hub for pharmaceutical innovation. Its flexibility and US-based operations position it well for clients seeking shorter supply chains. However, as a young company, it faces competition from established CDMOs and must demonstrate consistent quality and scalability.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Manufacturing Capacity70% success
• TBDStrategic Partnership with Mid-Size Pharma50% success
• Q4 2026FDA Inspection and cGMP Certification80% success